JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaJaroslav Žák, John R. Teijaro, Reza Beheshti Zavareh et al.|Science|2024Cited by 173
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapyJaroslav Žák, John R. Teijaro, Isaraphorn Pratumchai et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 6